176 related articles for article (PubMed ID: 19624548)
1. A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer.
Prior SL; Griffiths AP; Lewis PD
Br J Dermatol; 2009 Nov; 161(5):1067-71. PubMed ID: 19624548
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA mutations in oral squamous cell carcinoma.
Prior SL; Griffiths AP; Baxter JM; Baxter PW; Hodder SC; Silvester KC; Lewis PD
Carcinogenesis; 2006 May; 27(5):945-50. PubMed ID: 16407369
[TBL] [Abstract][Full Text] [Related]
3. Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers.
Pacifico A; Goldberg LH; Peris K; Chimenti S; Leone G; Ananthaswamy HN
Br J Dermatol; 2008 Feb; 158(2):291-7. PubMed ID: 18070208
[TBL] [Abstract][Full Text] [Related]
4. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
5. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.
Zaravinos A; Kanellou P; Spandidos DA
Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697
[TBL] [Abstract][Full Text] [Related]
6. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
[TBL] [Abstract][Full Text] [Related]
7. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA mutations in light-associated skin tumors.
Yang JH; Lee HC; Chung JG; Wei YH
Anticancer Res; 2004; 24(3a):1753-8. PubMed ID: 15274351
[TBL] [Abstract][Full Text] [Related]
9. Infrequent p53 mutations in arsenic-related skin lesions.
Castrén K; Ranki A; Welsh JA; Vähäkangas KH
Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
[TBL] [Abstract][Full Text] [Related]
10. p53 gene mutations in human epithelial skin cancers.
Molès JP; Moyret C; Guillot B; Jeanteur P; Guilhou JJ; Theillet C; Basset-Sèguin N
Oncogene; 1993 Mar; 8(3):583-8. PubMed ID: 8437842
[TBL] [Abstract][Full Text] [Related]
11. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
12. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
Tamori A; Nishiguchi S; Nishikawa M; Kubo S; Koh N; Hirohashi K; Shiomi S; Inoue M
J Gastroenterol; 2004 Nov; 39(11):1063-8. PubMed ID: 15580399
[TBL] [Abstract][Full Text] [Related]
13. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
[TBL] [Abstract][Full Text] [Related]
14. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
15. Carcinogen-specific mutation pattern in the p53 tumour suppressor gene in UV radiation-induced basal cell carcinoma.
Weihrauch M; Bader M; Lehnert G; Wittekind C; Tannapfel A; Wrbitzky R
Int Arch Occup Environ Health; 2002 Apr; 75(4):272-6. PubMed ID: 11981662
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
[TBL] [Abstract][Full Text] [Related]
17. Number of somatic mutations in the mitochondrial D-loop region indicates poor prognosis in breast cancer, independent of TP53 mutation.
Kuo SJ; Chen M; Ma GC; Chen ST; Chang SP; Lin WY; Chen YC; Lee TH; Lin TT; Liu CS
Cancer Genet Cytogenet; 2010 Sep; 201(2):94-101. PubMed ID: 20682393
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA mutations and 8-hydroxy-2'-deoxyguanosine Content in Japanese patients with urinary bladder and renal cancers.
Wada T; Tanji N; Ozawa A; Wang J; Shimamoto K; Sakayama K; Yokoyama M
Anticancer Res; 2006; 26(5A):3403-8. PubMed ID: 17094459
[TBL] [Abstract][Full Text] [Related]
19. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K
Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]